Literature DB >> 14607376

Understanding and preventing drug interactions in elderly patients.

Jeffrey C Delafuente1.   

Abstract

The elderly consume a disproportionate amount of prescription and nonprescription medications. Alterations in physiology, polypharmacy, multiple prescribers, and other factors place the elderly population at risk of developing clinically significant drug-drug interactions. The incidence of potential drug-drug interactions increases with increased drug use and are responsible for numerous emergency room and physician visits. Drug interactions have been shown to cause a decline in functional abilities in older people. Drugs can interact to alter the absorption, distribution, metabolism, or excretion of a drug or interact in a synergistic or antagonist fashion altering their pharmacodynamics. Drug interactions are often clinically unrecognized and responsible for increased morbidity in elderly patients. Prudent use of medications and vigilant drug monitoring are essential to avoid drug-drug interactions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607376     DOI: 10.1016/j.critrevonc.2003.04.004

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  43 in total

1.  The incidence of potential drug-drug interactions in elderly patients with arterial hypertension.

Authors:  Vesna Bacic-Vrca; Srecko Marusic; Viktorija Erdeljic; Slaven Falamic; Nives Gojo-Tomic; Dario Rahelic
Journal:  Pharm World Sci       Date:  2010-10-05

2.  Prevalence of potential drug-drug interactions in bone marrow transplant patients.

Authors:  Rosimeire Barbosa Fonseca Guastaldi; Adriano Max Moreira Reis; Albert Figueras; Silvia Regina Secoli
Journal:  Int J Clin Pharm       Date:  2011-10-13

3.  The unknown impacts of combinations of large numbers of drugs.

Authors:  Ronald N Kostoff; Jeffrey C Delafuente
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  [Thromboembolism prophylaxis in old age].

Authors:  Gabriele Röhrig; Gerald Kolb
Journal:  Z Gerontol Geriatr       Date:  2018-04-05       Impact factor: 1.281

5.  Challenges and opportunities in the design of age-appropriate drug products.

Authors:  S Stegemann
Journal:  Z Gerontol Geriatr       Date:  2012-08       Impact factor: 1.281

Review 6.  Pharmacoepidemiologic Methods for Studying the Health Effects of Drug-Drug Interactions.

Authors:  S Hennessy; C E Leonard; J J Gagne; J H Flory; X Han; C M Brensinger; W B Bilker
Journal:  Clin Pharmacol Ther       Date:  2015-11-23       Impact factor: 6.875

Review 7.  Hypnosedative-induced complex behaviours : incidence, mechanisms and management.

Authors:  Christian R Dolder; Michael H Nelson
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

8.  Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies.

Authors:  David Semel; T Kevin Murphy; Gergana Zlateva; Raymond Cheung; Birol Emir
Journal:  BMC Fam Pract       Date:  2010-11-05       Impact factor: 2.497

Review 9.  [Anticoagulation in geriatric patients with atrial fibrillation : With what and for whom no more?]

Authors:  P Bahrmann; M Christ
Journal:  Herz       Date:  2018-05       Impact factor: 1.443

10.  Oxybutynin extended release for the management of overactive bladder: a clinical review.

Authors:  A M Arisco; E K Brantly; S R Kraus
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.